| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 64 | 2024 | 352 | 9.830 |
Why?
|
| RNA, Long Noncoding | 20 | 2024 | 170 | 7.830 |
Why?
|
| Immunity, Innate | 72 | 2026 | 828 | 7.720 |
Why?
|
| Membrane Proteins | 48 | 2026 | 924 | 6.360 |
Why?
|
| Interferon Type I | 43 | 2026 | 197 | 6.230 |
Why?
|
| Inflammation | 52 | 2026 | 1194 | 6.180 |
Why?
|
| Signal Transduction | 122 | 2025 | 3156 | 5.560 |
Why?
|
| Gene Expression Regulation | 45 | 2022 | 1632 | 5.020 |
Why?
|
| Macrophages | 67 | 2025 | 1038 | 4.540 |
Why?
|
| Nucleotidyltransferases | 22 | 2026 | 66 | 4.520 |
Why?
|
| Animals | 267 | 2026 | 21394 | 3.970 |
Why?
|
| Toll-Like Receptors | 47 | 2020 | 434 | 3.880 |
Why?
|
| Interleukin-1beta | 43 | 2021 | 274 | 3.880 |
Why?
|
| Mice | 209 | 2026 | 11145 | 3.680 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 48 | 2023 | 263 | 3.490 |
Why?
|
| Pyroptosis | 10 | 2026 | 38 | 3.470 |
Why?
|
| Interferons | 13 | 2024 | 74 | 3.380 |
Why?
|
| Autoimmune Diseases | 9 | 2024 | 239 | 3.120 |
Why?
|
| Carrier Proteins | 41 | 2015 | 718 | 3.090 |
Why?
|
| DNA | 25 | 2026 | 852 | 2.730 |
Why?
|
| Immunity | 7 | 2021 | 107 | 2.630 |
Why?
|
| Caspase 1 | 28 | 2023 | 115 | 2.480 |
Why?
|
| Mice, Knockout | 104 | 2025 | 2162 | 2.420 |
Why?
|
| Mice, Inbred C57BL | 106 | 2025 | 3489 | 2.380 |
Why?
|
| Nuclear Proteins | 23 | 2023 | 790 | 2.260 |
Why?
|
| Interferon Regulatory Factor-3 | 37 | 2021 | 98 | 2.250 |
Why?
|
| Cytokines | 31 | 2023 | 956 | 2.250 |
Why?
|
| Autoimmunity | 10 | 2024 | 249 | 2.150 |
Why?
|
| DNA-Binding Proteins | 33 | 2021 | 1225 | 2.110 |
Why?
|
| Toll-Like Receptor 4 | 36 | 2025 | 350 | 2.100 |
Why?
|
| Cytosol | 16 | 2019 | 182 | 2.090 |
Why?
|
| Virus Diseases | 9 | 2020 | 117 | 1.950 |
Why?
|
| Humans | 212 | 2026 | 65498 | 1.940 |
Why?
|
| RNA, Viral | 14 | 2023 | 266 | 1.930 |
Why?
|
| RNA-Binding Proteins | 8 | 2025 | 446 | 1.910 |
Why?
|
| Membrane Glycoproteins | 27 | 2018 | 662 | 1.890 |
Why?
|
| Caspase 8 | 12 | 2025 | 66 | 1.790 |
Why?
|
| Colitis | 6 | 2024 | 77 | 1.730 |
Why?
|
| Lipopolysaccharides | 31 | 2020 | 625 | 1.670 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 25 | 2015 | 81 | 1.620 |
Why?
|
| DEAD-box RNA Helicases | 14 | 2017 | 132 | 1.620 |
Why?
|
| Receptors, Pattern Recognition | 7 | 2016 | 36 | 1.600 |
Why?
|
| Apoptosis Regulatory Proteins | 15 | 2019 | 152 | 1.590 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 12 | 2020 | 345 | 1.570 |
Why?
|
| Phosphate-Binding Proteins | 5 | 2022 | 20 | 1.490 |
Why?
|
| Myeloid Differentiation Factor 88 | 39 | 2017 | 203 | 1.480 |
Why?
|
| Neoplasms | 8 | 2026 | 1372 | 1.450 |
Why?
|
| Transcription, Genetic | 14 | 2021 | 908 | 1.370 |
Why?
|
| Host-Pathogen Interactions | 14 | 2025 | 279 | 1.350 |
Why?
|
| Caspases | 6 | 2022 | 176 | 1.350 |
Why?
|
| Dendritic Cells | 29 | 2025 | 531 | 1.320 |
Why?
|
| NF-kappa B | 26 | 2023 | 435 | 1.320 |
Why?
|
| Receptors, Cell Surface | 17 | 2007 | 431 | 1.240 |
Why?
|
| Vascular Diseases | 2 | 2022 | 83 | 1.230 |
Why?
|
| Interferon-beta | 22 | 2018 | 79 | 1.220 |
Why?
|
| Cells, Cultured | 53 | 2020 | 2188 | 1.160 |
Why?
|
| RNA Viruses | 5 | 2021 | 10 | 1.140 |
Why?
|
| Receptors, Immunologic | 19 | 2011 | 179 | 1.120 |
Why?
|
| Cell Line | 48 | 2022 | 2024 | 1.100 |
Why?
|
| Transcription Factors | 15 | 2023 | 1557 | 1.100 |
Why?
|
| Cell Death | 12 | 2025 | 289 | 1.080 |
Why?
|
| Immune Evasion | 3 | 2024 | 71 | 1.060 |
Why?
|
| Cytoskeletal Proteins | 13 | 2019 | 204 | 1.060 |
Why?
|
| RNA Virus Infections | 3 | 2021 | 4 | 1.050 |
Why?
|
| Adaptive Immunity | 7 | 2025 | 105 | 1.050 |
Why?
|
| Mitochondria | 8 | 2025 | 410 | 1.050 |
Why?
|
| Influenza A virus | 4 | 2025 | 120 | 1.040 |
Why?
|
| DNA, Bacterial | 7 | 2016 | 261 | 1.040 |
Why?
|
| Endothelial Cells | 3 | 2026 | 213 | 1.030 |
Why?
|
| Toll-Like Receptor 9 | 13 | 2018 | 207 | 1.010 |
Why?
|
| Viruses | 3 | 2020 | 81 | 1.010 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2021 | 183 | 1.010 |
Why?
|
| T-Lymphocytes | 15 | 2026 | 1008 | 1.000 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 10 | 2025 | 84 | 0.990 |
Why?
|
| Myeloid Cells | 3 | 2022 | 98 | 0.970 |
Why?
|
| Genetic Vectors | 6 | 2025 | 926 | 0.970 |
Why?
|
| Hereditary Autoinflammatory Diseases | 2 | 2023 | 3 | 0.960 |
Why?
|
| Listeriosis | 5 | 2020 | 29 | 0.960 |
Why?
|
| Influenza, Human | 4 | 2025 | 210 | 0.950 |
Why?
|
| Interleukin-18 | 11 | 2021 | 75 | 0.950 |
Why?
|
| Apoptosis | 11 | 2023 | 1098 | 0.940 |
Why?
|
| DNA Viruses | 5 | 2019 | 16 | 0.940 |
Why?
|
| Virus Replication | 10 | 2025 | 323 | 0.930 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2024 | 110 | 0.920 |
Why?
|
| Receptors, Interleukin-1 | 11 | 2013 | 64 | 0.920 |
Why?
|
| Th1 Cells | 5 | 2018 | 171 | 0.880 |
Why?
|
| Phosphoproteins | 8 | 2014 | 224 | 0.880 |
Why?
|
| Adaptor Proteins, Signal Transducing | 25 | 2019 | 441 | 0.860 |
Why?
|
| DNA, Viral | 10 | 2015 | 232 | 0.850 |
Why?
|
| Tumor Escape | 1 | 2024 | 16 | 0.840 |
Why?
|
| Francisella tularensis | 3 | 2015 | 19 | 0.840 |
Why?
|
| Intestinal Mucosa | 6 | 2024 | 250 | 0.830 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 28 | 0.830 |
Why?
|
| Malaria | 4 | 2025 | 159 | 0.820 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 103 | 0.810 |
Why?
|
| Listeria monocytogenes | 6 | 2020 | 33 | 0.810 |
Why?
|
| Disease Models, Animal | 21 | 2026 | 2307 | 0.800 |
Why?
|
| Ubiquitination | 5 | 2021 | 123 | 0.800 |
Why?
|
| Candidiasis | 3 | 2014 | 49 | 0.790 |
Why?
|
| Candida albicans | 3 | 2014 | 61 | 0.780 |
Why?
|
| GTP-Binding Proteins | 2 | 2015 | 93 | 0.780 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2022 | 4 | 0.770 |
Why?
|
| Familial Mediterranean Fever | 2 | 2020 | 9 | 0.770 |
Why?
|
| Gain of Function Mutation | 4 | 2026 | 20 | 0.770 |
Why?
|
| Tularemia | 2 | 2015 | 13 | 0.760 |
Why?
|
| Genetic Therapy | 4 | 2025 | 849 | 0.760 |
Why?
|
| Adjuvants, Immunologic | 7 | 2026 | 236 | 0.760 |
Why?
|
| Immune System | 2 | 2014 | 132 | 0.750 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2022 | 8 | 0.740 |
Why?
|
| Caspase 7 | 1 | 2022 | 17 | 0.740 |
Why?
|
| Monocytes | 13 | 2024 | 361 | 0.710 |
Why?
|
| Cytoplasm | 2 | 2013 | 283 | 0.700 |
Why?
|
| Self Tolerance | 2 | 2015 | 20 | 0.700 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2024 | 145 | 0.700 |
Why?
|
| Interferon Regulatory Factors | 11 | 2024 | 43 | 0.690 |
Why?
|
| Cell Nucleus | 11 | 2023 | 631 | 0.690 |
Why?
|
| Th17 Cells | 3 | 2018 | 63 | 0.690 |
Why?
|
| Interferon-gamma | 11 | 2025 | 575 | 0.680 |
Why?
|
| Toll-Like Receptor 3 | 14 | 2017 | 66 | 0.680 |
Why?
|
| Toll-Like Receptor 7 | 10 | 2018 | 104 | 0.680 |
Why?
|
| HEK293 Cells | 16 | 2021 | 617 | 0.670 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 169 | 0.660 |
Why?
|
| Proteins | 6 | 2020 | 764 | 0.660 |
Why?
|
| Herpesvirus 1, Human | 10 | 2025 | 83 | 0.650 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 227 | 0.650 |
Why?
|
| Neutrophils | 3 | 2021 | 395 | 0.650 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.650 |
Why?
|
| Toll-Like Receptor 2 | 14 | 2019 | 219 | 0.650 |
Why?
|
| DNA, Protozoan | 4 | 2017 | 51 | 0.640 |
Why?
|
| Dysbiosis | 1 | 2021 | 74 | 0.630 |
Why?
|
| Inflammation Mediators | 10 | 2015 | 179 | 0.630 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 60 | 0.630 |
Why?
|
| Lymphocyte Activation | 16 | 2021 | 754 | 0.630 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2019 | 61 | 0.620 |
Why?
|
| Cysteine | 1 | 2020 | 108 | 0.620 |
Why?
|
| CARD Signaling Adaptor Proteins | 12 | 2024 | 66 | 0.610 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2019 | 10 | 0.610 |
Why?
|
| Interferon Regulatory Factor-7 | 9 | 2021 | 33 | 0.600 |
Why?
|
| DNA, Neoplasm | 1 | 2019 | 62 | 0.600 |
Why?
|
| Xanthones | 4 | 2018 | 6 | 0.590 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2018 | 248 | 0.580 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2018 | 18 | 0.580 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 156 | 0.570 |
Why?
|
| Gram-Negative Bacteria | 5 | 2017 | 56 | 0.570 |
Why?
|
| RNA | 8 | 2023 | 426 | 0.570 |
Why?
|
| Immunity, Cellular | 2 | 2018 | 170 | 0.560 |
Why?
|
| Hemeproteins | 3 | 2014 | 17 | 0.550 |
Why?
|
| Histones | 2 | 2020 | 497 | 0.540 |
Why?
|
| Immunologic Surveillance | 4 | 2025 | 22 | 0.540 |
Why?
|
| Herpesviridae Infections | 3 | 2015 | 25 | 0.530 |
Why?
|
| Peptide Fragments | 1 | 2019 | 417 | 0.530 |
Why?
|
| Autoantibodies | 8 | 2022 | 185 | 0.530 |
Why?
|
| Lung | 8 | 2024 | 969 | 0.520 |
Why?
|
| Protein Binding | 16 | 2021 | 1632 | 0.520 |
Why?
|
| Receptors, Interleukin | 10 | 2014 | 38 | 0.510 |
Why?
|
| Enterohemorrhagic Escherichia coli | 3 | 2014 | 13 | 0.500 |
Why?
|
| RNA Splicing | 4 | 2025 | 171 | 0.500 |
Why?
|
| Bacterial Infections | 3 | 2014 | 150 | 0.500 |
Why?
|
| Immune System Diseases | 1 | 2017 | 19 | 0.500 |
Why?
|
| Gene Expression | 10 | 2021 | 854 | 0.490 |
Why?
|
| DNA Damage | 2 | 2018 | 298 | 0.480 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2015 | 5 | 0.480 |
Why?
|
| Citrobacter rodentium | 2 | 2014 | 5 | 0.480 |
Why?
|
| Drosophila Proteins | 5 | 2006 | 758 | 0.470 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 18 | 0.470 |
Why?
|
| Second Messenger Systems | 2 | 2013 | 27 | 0.470 |
Why?
|
| Protein Kinases | 5 | 2023 | 153 | 0.470 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 151 | 0.470 |
Why?
|
| Nucleic Acids | 2 | 2016 | 66 | 0.450 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 8 | 0.450 |
Why?
|
| Bacteriolysis | 1 | 2015 | 7 | 0.450 |
Why?
|
| Malaria, Falciparum | 5 | 2022 | 235 | 0.450 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2013 | 242 | 0.450 |
Why?
|
| Lectins, C-Type | 2 | 2018 | 80 | 0.440 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2015 | 7 | 0.440 |
Why?
|
| I-kappa B Kinase | 8 | 2018 | 50 | 0.440 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 86 | 0.440 |
Why?
|
| Interleukin-1alpha | 3 | 2015 | 25 | 0.430 |
Why?
|
| Biosensing Techniques | 2 | 2013 | 126 | 0.430 |
Why?
|
| Down-Regulation | 5 | 2020 | 324 | 0.430 |
Why?
|
| Fungal Polysaccharides | 1 | 2014 | 4 | 0.430 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 241 | 0.430 |
Why?
|
| Molecular Biology | 1 | 2015 | 65 | 0.430 |
Why?
|
| Macrophage-1 Antigen | 1 | 2014 | 29 | 0.420 |
Why?
|
| Chemokine CCL8 | 1 | 2014 | 4 | 0.410 |
Why?
|
| beta-Glucans | 1 | 2014 | 51 | 0.410 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2019 | 226 | 0.410 |
Why?
|
| RNA, Double-Stranded | 8 | 2015 | 112 | 0.410 |
Why?
|
| Plasmodium | 3 | 2024 | 34 | 0.400 |
Why?
|
| Receptor, Interferon alpha-beta | 6 | 2021 | 54 | 0.400 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 5 | 2024 | 34 | 0.390 |
Why?
|
| Cancer Vaccines | 2 | 2025 | 51 | 0.390 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 52 | 0.390 |
Why?
|
| Macrophages, Peritoneal | 8 | 2024 | 75 | 0.390 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 220 | 0.390 |
Why?
|
| Cyclic GMP | 5 | 2023 | 33 | 0.390 |
Why?
|
| Female | 42 | 2026 | 34216 | 0.390 |
Why?
|
| Ligands | 12 | 2024 | 414 | 0.380 |
Why?
|
| RNA, Messenger | 10 | 2020 | 1577 | 0.380 |
Why?
|
| Cell Line, Tumor | 10 | 2026 | 1568 | 0.370 |
Why?
|
| Plasmodium chabaudi | 3 | 2025 | 30 | 0.370 |
Why?
|
| MicroRNAs | 5 | 2020 | 714 | 0.360 |
Why?
|
| Homeostasis | 3 | 2024 | 380 | 0.360 |
Why?
|
| Gene Knockdown Techniques | 5 | 2020 | 204 | 0.360 |
Why?
|
| Streptococcus agalactiae | 4 | 2016 | 81 | 0.360 |
Why?
|
| Hepatocytes | 5 | 2016 | 222 | 0.350 |
Why?
|
| Encephalitis, Herpes Simplex | 2 | 2025 | 9 | 0.350 |
Why?
|
| Virus Physiological Phenomena | 1 | 2011 | 8 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 7 | 2021 | 687 | 0.340 |
Why?
|
| NLR Proteins | 2 | 2023 | 11 | 0.340 |
Why?
|
| Protein Transport | 7 | 2020 | 405 | 0.340 |
Why?
|
| Chemokine CCL5 | 6 | 2014 | 32 | 0.340 |
Why?
|
| Mice, Mutant Strains | 8 | 2021 | 301 | 0.340 |
Why?
|
| Intestines | 2 | 2024 | 182 | 0.340 |
Why?
|
| Transfection | 10 | 2024 | 700 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2025 | 604 | 0.340 |
Why?
|
| Herpesviridae | 1 | 2011 | 15 | 0.330 |
Why?
|
| Endosomes | 5 | 2016 | 180 | 0.330 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2016 | 53 | 0.330 |
Why?
|
| Immunoglobulin E | 2 | 2026 | 81 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 2022 | 16 | 0.330 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2022 | 422 | 0.320 |
Why?
|
| Antigens, Differentiation | 11 | 2005 | 144 | 0.320 |
Why?
|
| Mutation | 11 | 2021 | 2666 | 0.320 |
Why?
|
| Membrane Transport Proteins | 7 | 2016 | 135 | 0.320 |
Why?
|
| CRISPR-Cas Systems | 5 | 2025 | 369 | 0.320 |
Why?
|
| Catenins | 1 | 2010 | 14 | 0.320 |
Why?
|
| Adenoviridae | 2 | 2016 | 130 | 0.320 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2010 | 1 | 0.320 |
Why?
|
| DNA Virus Infections | 1 | 2010 | 8 | 0.320 |
Why?
|
| Gene Deletion | 5 | 2018 | 312 | 0.310 |
Why?
|
| Interleukin-1 | 6 | 2023 | 154 | 0.310 |
Why?
|
| Viral Interference | 1 | 2009 | 1 | 0.310 |
Why?
|
| Nucleotides, Cyclic | 4 | 2025 | 16 | 0.310 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2007 | 47 | 0.310 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2020 | 8 | 0.310 |
Why?
|
| Plasmodium falciparum | 4 | 2022 | 258 | 0.310 |
Why?
|
| Metapneumovirus | 1 | 2009 | 7 | 0.310 |
Why?
|
| Lymphocytes | 3 | 2024 | 209 | 0.310 |
Why?
|
| Rift Valley Fever | 3 | 2013 | 4 | 0.300 |
Why?
|
| Rift Valley fever virus | 3 | 2013 | 4 | 0.300 |
Why?
|
| Macrophage Activation | 3 | 2020 | 115 | 0.300 |
Why?
|
| Integrin beta3 | 1 | 2009 | 8 | 0.300 |
Why?
|
| Microglia | 3 | 2025 | 250 | 0.300 |
Why?
|
| Autophagy | 4 | 2013 | 238 | 0.300 |
Why?
|
| Enzyme Activation | 9 | 2020 | 391 | 0.290 |
Why?
|
| Endodeoxyribonucleases | 4 | 2017 | 44 | 0.290 |
Why?
|
| Viral Load | 3 | 2024 | 230 | 0.290 |
Why?
|
| RNA Helicases | 3 | 2006 | 99 | 0.290 |
Why?
|
| Chromatin | 4 | 2023 | 643 | 0.290 |
Why?
|
| Calcium-Binding Proteins | 3 | 2014 | 94 | 0.290 |
Why?
|
| Myelin Proteins | 5 | 2010 | 30 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2020 | 449 | 0.290 |
Why?
|
| Nanoparticles | 2 | 2025 | 548 | 0.290 |
Why?
|
| Proteolipids | 5 | 2010 | 23 | 0.280 |
Why?
|
| Pyrin | 2 | 2020 | 8 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2023 | 69 | 0.280 |
Why?
|
| Immunologic Memory | 2 | 2026 | 284 | 0.280 |
Why?
|
| RNA Stability | 2 | 2022 | 104 | 0.280 |
Why?
|
| DEAD Box Protein 58 | 9 | 2013 | 21 | 0.280 |
Why?
|
| Cell Differentiation | 8 | 2024 | 1387 | 0.280 |
Why?
|
| Armadillo Domain Proteins | 4 | 2019 | 27 | 0.280 |
Why?
|
| RNA Polymerase II | 3 | 2023 | 86 | 0.280 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 42 | 0.280 |
Why?
|
| RNA Interference | 7 | 2016 | 644 | 0.280 |
Why?
|
| Interferon-alpha | 7 | 2014 | 101 | 0.270 |
Why?
|
| Male | 28 | 2025 | 31208 | 0.270 |
Why?
|
| DNA, Mitochondrial | 4 | 2025 | 86 | 0.270 |
Why?
|
| Cyclooxygenase 2 | 4 | 2018 | 61 | 0.270 |
Why?
|
| Tuberculosis | 3 | 2022 | 312 | 0.270 |
Why?
|
| TNF Receptor-Associated Factor 6 | 5 | 2020 | 27 | 0.260 |
Why?
|
| Phosphorylation | 14 | 2020 | 962 | 0.260 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 183 | 0.260 |
Why?
|
| Plague | 3 | 2018 | 23 | 0.260 |
Why?
|
| Interleukin-10 | 2 | 2025 | 165 | 0.250 |
Why?
|
| Lipid A | 1 | 2007 | 68 | 0.250 |
Why?
|
| Immunotherapy | 3 | 2025 | 273 | 0.250 |
Why?
|
| Molecular Sequence Data | 13 | 2014 | 1979 | 0.250 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2006 | 1 | 0.250 |
Why?
|
| Caspases, Initiator | 4 | 2014 | 9 | 0.250 |
Why?
|
| Antigens, Surface | 6 | 2004 | 199 | 0.250 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2006 | 21 | 0.240 |
Why?
|
| Membrane Lipids | 1 | 2006 | 25 | 0.240 |
Why?
|
| Bacterial Proteins | 7 | 2018 | 741 | 0.240 |
Why?
|
| Succinates | 2 | 2024 | 10 | 0.240 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 17 | 0.240 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2018 | 83 | 0.240 |
Why?
|
| Cell Membrane | 5 | 2022 | 506 | 0.240 |
Why?
|
| Trans-Activators | 2 | 2021 | 321 | 0.240 |
Why?
|
| Mucous Membrane | 2 | 2018 | 26 | 0.240 |
Why?
|
| Basophils | 1 | 2026 | 15 | 0.240 |
Why?
|
| Fas Ligand Protein | 2 | 2018 | 40 | 0.240 |
Why?
|
| Dependovirus | 2 | 2025 | 758 | 0.240 |
Why?
|
| Alkynes | 1 | 2026 | 28 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2024 | 184 | 0.230 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2023 | 13 | 0.230 |
Why?
|
| Amides | 1 | 2026 | 60 | 0.230 |
Why?
|
| Mast Cells | 1 | 2026 | 51 | 0.230 |
Why?
|
| Food Hypersensitivity | 1 | 2026 | 26 | 0.230 |
Why?
|
| Thiolester Hydrolases | 1 | 2025 | 10 | 0.230 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 1290 | 0.230 |
Why?
|
| Biomarkers | 3 | 2021 | 1484 | 0.230 |
Why?
|
| Arthritis, Experimental | 2 | 2016 | 30 | 0.230 |
Why?
|
| A549 Cells | 2 | 2025 | 39 | 0.230 |
Why?
|
| Phenotype | 5 | 2024 | 1233 | 0.230 |
Why?
|
| Lymph Nodes | 1 | 2026 | 237 | 0.220 |
Why?
|
| Uric Acid | 2 | 2015 | 47 | 0.220 |
Why?
|
| Dinucleoside Phosphates | 2 | 2016 | 32 | 0.220 |
Why?
|
| Flow Cytometry | 11 | 2016 | 663 | 0.220 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 301 | 0.220 |
Why?
|
| Ultraviolet Rays | 1 | 2026 | 153 | 0.220 |
Why?
|
| Sendai virus | 4 | 2016 | 11 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 3 | 2013 | 235 | 0.220 |
Why?
|
| Endotoxins | 3 | 2014 | 81 | 0.210 |
Why?
|
| RNA, Small Interfering | 7 | 2023 | 982 | 0.210 |
Why?
|
| Vaccines, DNA | 2 | 2015 | 98 | 0.210 |
Why?
|
| Poly I-C | 3 | 2021 | 76 | 0.210 |
Why?
|
| Skin | 2 | 2026 | 428 | 0.210 |
Why?
|
| Methylcellulose | 1 | 2024 | 5 | 0.210 |
Why?
|
| Gene Expression Profiling | 8 | 2017 | 796 | 0.210 |
Why?
|
| THP-1 Cells | 2 | 2021 | 23 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 117 | 0.210 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 2 | 2022 | 3 | 0.210 |
Why?
|
| Yersinia pestis | 3 | 2014 | 33 | 0.210 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2024 | 44 | 0.210 |
Why?
|
| Microscopy, Confocal | 9 | 2015 | 240 | 0.210 |
Why?
|
| Repressor Proteins | 1 | 2006 | 351 | 0.210 |
Why?
|
| Lysosomes | 6 | 2014 | 174 | 0.210 |
Why?
|
| RNA, Untranslated | 2 | 2015 | 105 | 0.210 |
Why?
|
| Toxoplasmosis | 1 | 2024 | 21 | 0.200 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 170 | 0.200 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.200 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 1588 | 0.200 |
Why?
|
| Vaccination | 2 | 2025 | 385 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 3 | 2020 | 70 | 0.200 |
Why?
|
| Phagosomes | 3 | 2014 | 44 | 0.200 |
Why?
|
| Protons | 1 | 2023 | 67 | 0.200 |
Why?
|
| Immunoblotting | 10 | 2016 | 202 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 10 | 2014 | 672 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2024 | 413 | 0.200 |
Why?
|
| Spleen | 5 | 2020 | 476 | 0.190 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 76 | 0.190 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 153 | 0.190 |
Why?
|
| Host-Parasite Interactions | 2 | 2013 | 61 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 1 | 2025 | 152 | 0.190 |
Why?
|
| Transcriptional Activation | 3 | 2013 | 196 | 0.190 |
Why?
|
| Klebsiella pneumoniae | 1 | 2023 | 29 | 0.190 |
Why?
|
| Osteoclasts | 1 | 2023 | 53 | 0.190 |
Why?
|
| Herpes Simplex | 3 | 2018 | 49 | 0.190 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2015 | 93 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 128 | 0.190 |
Why?
|
| Cell Movement | 2 | 2022 | 482 | 0.190 |
Why?
|
| B-Lymphocytes | 7 | 2018 | 563 | 0.190 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2022 | 7 | 0.190 |
Why?
|
| Interleukin-12 | 4 | 2024 | 127 | 0.190 |
Why?
|
| Perforin | 1 | 2022 | 26 | 0.190 |
Why?
|
| Keratinocytes | 1 | 2023 | 72 | 0.190 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 35 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 268 | 0.180 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 34 | 0.180 |
Why?
|
| Antiviral Agents | 5 | 2023 | 326 | 0.180 |
Why?
|
| Lymphoid Tissue | 1 | 2022 | 54 | 0.180 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 21 | 0.180 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2014 | 26 | 0.180 |
Why?
|
| Lymphocyte Depletion | 1 | 2022 | 96 | 0.180 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2009 | 149 | 0.180 |
Why?
|
| Neurons | 3 | 2025 | 934 | 0.180 |
Why?
|
| Radiation Tolerance | 1 | 2022 | 56 | 0.180 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 20 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1039 | 0.180 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2021 | 6 | 0.180 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 29 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 325 | 0.180 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 89 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 677 | 0.180 |
Why?
|
| Ligases | 1 | 2001 | 27 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 102 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2018 | 199 | 0.170 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2021 | 8 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2023 | 133 | 0.170 |
Why?
|
| Models, Genetic | 2 | 2018 | 267 | 0.170 |
Why?
|
| Liver | 3 | 2015 | 871 | 0.170 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 23 | 0.170 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2012 | 88 | 0.170 |
Why?
|
| Biological Phenomena | 1 | 2020 | 4 | 0.170 |
Why?
|
| Axons | 1 | 2001 | 124 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 10 | 2018 | 868 | 0.170 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 2 | 2014 | 9 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 354 | 0.160 |
Why?
|
| Erythrocytes | 4 | 2017 | 146 | 0.160 |
Why?
|
| Streptococcus pneumoniae | 2 | 2011 | 67 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2020 | 61 | 0.160 |
Why?
|
| Histone Deacetylase 6 | 1 | 2020 | 8 | 0.160 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 498 | 0.160 |
Why?
|
| Immunophenotyping | 1 | 2021 | 194 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 179 | 0.160 |
Why?
|
| Feedback | 1 | 2020 | 91 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 29 | 0.160 |
Why?
|
| Arthritis, Gouty | 1 | 2020 | 2 | 0.160 |
Why?
|
| Provitamins | 1 | 2020 | 2 | 0.160 |
Why?
|
| Malaria, Cerebral | 1 | 2020 | 24 | 0.160 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 2019 | 8 | 0.160 |
Why?
|
| Reactive Oxygen Species | 6 | 2023 | 237 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 139 | 0.160 |
Why?
|
| RNA Precursors | 1 | 2020 | 78 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2024 | 900 | 0.160 |
Why?
|
| Organelles | 1 | 2020 | 21 | 0.160 |
Why?
|
| Interleukins | 1 | 2020 | 88 | 0.160 |
Why?
|
| Atherosclerosis | 2 | 2013 | 162 | 0.160 |
Why?
|
| Breast | 1 | 2001 | 192 | 0.150 |
Why?
|
| Antineoplastic Agents | 4 | 2013 | 643 | 0.150 |
Why?
|
| beta Carotene | 1 | 2020 | 67 | 0.150 |
Why?
|
| Protein Prenylation | 1 | 2019 | 6 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 17 | 0.150 |
Why?
|
| Poly dA-dT | 2 | 2009 | 8 | 0.150 |
Why?
|
| Spermatozoa | 1 | 2001 | 267 | 0.150 |
Why?
|
| Telomerase | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cluster Analysis | 3 | 2015 | 267 | 0.150 |
Why?
|
| Vaccinia virus | 3 | 2011 | 69 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 428 | 0.150 |
Why?
|
| Melanoma | 2 | 2021 | 333 | 0.140 |
Why?
|
| Crystallography, X-Ray | 3 | 2012 | 413 | 0.140 |
Why?
|
| Child | 5 | 2022 | 4623 | 0.140 |
Why?
|
| Neuropeptides | 1 | 2019 | 81 | 0.140 |
Why?
|
| Protein Multimerization | 3 | 2016 | 181 | 0.140 |
Why?
|
| Francisella | 1 | 2018 | 3 | 0.140 |
Why?
|
| Polyubiquitin | 2 | 2008 | 9 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 29 | 0.140 |
Why?
|
| Luciferases | 4 | 2013 | 107 | 0.140 |
Why?
|
| Mammals | 3 | 2022 | 222 | 0.140 |
Why?
|
| Herpesvirus 2, Human | 1 | 2018 | 14 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 921 | 0.140 |
Why?
|
| Genes, Reporter | 6 | 2016 | 257 | 0.140 |
Why?
|
| NADPH Oxidases | 3 | 2013 | 69 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2018 | 25 | 0.140 |
Why?
|
| Oligonucleotides | 3 | 2023 | 229 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 33 | 0.140 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 154 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 515 | 0.140 |
Why?
|
| Cholesterol | 2 | 2010 | 261 | 0.140 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2018 | 16 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 542 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1143 | 0.140 |
Why?
|
| Phagocytosis | 3 | 2014 | 257 | 0.130 |
Why?
|
| Paracoccidioidomycosis | 1 | 2018 | 25 | 0.130 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 25 | 0.130 |
Why?
|
| Paracoccidioides | 1 | 2018 | 37 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2025 | 642 | 0.130 |
Why?
|
| Peritonitis | 2 | 2016 | 43 | 0.130 |
Why?
|
| Bone Marrow Cells | 6 | 2016 | 237 | 0.130 |
Why?
|
| Aminoquinolines | 2 | 2015 | 16 | 0.130 |
Why?
|
| Geographic Atrophy | 1 | 2017 | 20 | 0.130 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 5 | 2010 | 11 | 0.130 |
Why?
|
| Gram-Positive Bacteria | 2 | 2012 | 35 | 0.130 |
Why?
|
| Bacterial Secretion Systems | 2 | 2016 | 11 | 0.130 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2017 | 204 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2014 | 422 | 0.130 |
Why?
|
| 5' Untranslated Regions | 1 | 2017 | 28 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2018 | 211 | 0.130 |
Why?
|
| Genome, Viral | 2 | 2008 | 145 | 0.120 |
Why?
|
| Pyrophosphatases | 1 | 2016 | 11 | 0.120 |
Why?
|
| Respirovirus Infections | 1 | 2016 | 6 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 88 | 0.120 |
Why?
|
| Chromatids | 1 | 2016 | 15 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 7 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2013 | 376 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2014 | 156 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 46 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 53 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2013 | 31 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2016 | 67 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 89 | 0.120 |
Why?
|
| Interleukin-6 | 5 | 2022 | 323 | 0.120 |
Why?
|
| Cellular Microenvironment | 1 | 2015 | 23 | 0.120 |
Why?
|
| Caspase 2 | 1 | 2015 | 7 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 2014 | 332 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2017 | 152 | 0.110 |
Why?
|
| Probenecid | 1 | 2015 | 5 | 0.110 |
Why?
|
| src-Family Kinases | 3 | 2012 | 64 | 0.110 |
Why?
|
| Czechoslovakia | 1 | 2015 | 1 | 0.110 |
Why?
|
| Salmonella Infections | 2 | 2013 | 42 | 0.110 |
Why?
|
| Allopurinol | 1 | 2015 | 15 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2014 | 138 | 0.110 |
Why?
|
| Arthritis | 1 | 2015 | 52 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2016 | 78 | 0.110 |
Why?
|
| Transcriptome | 2 | 2016 | 399 | 0.110 |
Why?
|
| RNA, Antisense | 1 | 2015 | 50 | 0.110 |
Why?
|
| Models, Immunological | 2 | 2013 | 85 | 0.110 |
Why?
|
| Toll-Like Receptor 8 | 3 | 2014 | 49 | 0.110 |
Why?
|
| Gammaherpesvirinae | 1 | 2015 | 4 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 2 | 2005 | 69 | 0.110 |
Why?
|
| Chitosan | 1 | 2016 | 88 | 0.110 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2015 | 33 | 0.110 |
Why?
|
| Psoriasis | 1 | 2015 | 59 | 0.110 |
Why?
|
| Viral Proteins | 3 | 2010 | 270 | 0.110 |
Why?
|
| Virus Latency | 1 | 2015 | 31 | 0.110 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 181 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2014 | 110 | 0.110 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2014 | 11 | 0.110 |
Why?
|
| Genetic Loci | 2 | 2015 | 116 | 0.110 |
Why?
|
| Salmonella typhimurium | 3 | 2013 | 86 | 0.110 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 7 | 0.110 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 14 | 0.100 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 15 | 0.100 |
Why?
|
| Peritoneum | 1 | 2014 | 31 | 0.100 |
Why?
|
| Potassium | 4 | 2018 | 98 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2015 | 180 | 0.100 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 22 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 2 | 2014 | 178 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 300 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2015 | 233 | 0.100 |
Why?
|
| Pneumococcal Infections | 2 | 2011 | 39 | 0.100 |
Why?
|
| Polyadenylation | 1 | 2014 | 51 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 766 | 0.100 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 73 | 0.100 |
Why?
|
| Vero Cells | 2 | 2013 | 81 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2013 | 8 | 0.100 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 49 | 0.100 |
Why?
|
| Toxoplasma | 1 | 2013 | 34 | 0.100 |
Why?
|
| Thionucleotides | 1 | 2013 | 39 | 0.100 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 45 | 0.100 |
Why?
|
| Gadolinium | 1 | 2014 | 110 | 0.100 |
Why?
|
| CD36 Antigens | 1 | 2013 | 26 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 3 | 2019 | 177 | 0.100 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 82 | 0.100 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2022 | 95 | 0.100 |
Why?
|
| Plasmodium vivax | 1 | 2014 | 55 | 0.100 |
Why?
|
| Introns | 1 | 2013 | 114 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 29 | 0.100 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 56 | 0.100 |
Why?
|
| DNA, Single-Stranded | 1 | 2014 | 108 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2013 | 99 | 0.100 |
Why?
|
| Dimerization | 5 | 2019 | 145 | 0.100 |
Why?
|
| Exodeoxyribonucleases | 1 | 2013 | 29 | 0.100 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2013 | 6 | 0.100 |
Why?
|
| Arthritis, Infectious | 1 | 2013 | 20 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 72 | 0.090 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 23 | 0.090 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 41 | 0.090 |
Why?
|
| Serine O-Acetyltransferase | 1 | 2012 | 3 | 0.090 |
Why?
|
| Oligoribonucleotides | 2 | 2009 | 16 | 0.090 |
Why?
|
| Prions | 1 | 2012 | 27 | 0.090 |
Why?
|
| fas Receptor | 1 | 2012 | 56 | 0.090 |
Why?
|
| Cell Fusion | 1 | 2012 | 39 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 133 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2012 | 52 | 0.090 |
Why?
|
| DNA, B-Form | 1 | 2012 | 3 | 0.090 |
Why?
|
| Fetal Death | 1 | 2012 | 15 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2009 | 49 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 214 | 0.090 |
Why?
|
| Cytomegalovirus | 1 | 2013 | 94 | 0.090 |
Why?
|
| Epithelium, Corneal | 1 | 2012 | 9 | 0.090 |
Why?
|
| Membrane Fusion | 1 | 2012 | 67 | 0.090 |
Why?
|
| Microbiota | 1 | 2014 | 169 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 168 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 62 | 0.090 |
Why?
|
| Capsid | 1 | 2013 | 104 | 0.090 |
Why?
|
| Myxoma virus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2012 | 164 | 0.090 |
Why?
|
| AT Rich Sequence | 1 | 2011 | 5 | 0.090 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 468 | 0.090 |
Why?
|
| Contrast Media | 1 | 2014 | 432 | 0.090 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2011 | 11 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 7 | 0.090 |
Why?
|
| Time Factors | 6 | 2014 | 3774 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 267 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 72 | 0.080 |
Why?
|
| Cell Survival | 3 | 2019 | 588 | 0.080 |
Why?
|
| Allergens | 1 | 2011 | 54 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2011 | 41 | 0.080 |
Why?
|
| Molecular Docking Simulation | 2 | 2022 | 81 | 0.080 |
Why?
|
| Respiratory System | 1 | 2011 | 46 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 363 | 0.080 |
Why?
|
| Streptolysins | 1 | 2010 | 9 | 0.080 |
Why?
|
| Rats | 3 | 2026 | 1996 | 0.080 |
Why?
|
| Yersinia Infections | 2 | 2025 | 10 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2010 | 33 | 0.080 |
Why?
|
| Alleles | 3 | 2019 | 455 | 0.080 |
Why?
|
| Vesicular Stomatitis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 86 | 0.080 |
Why?
|
| Premature Birth | 1 | 2012 | 116 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 586 | 0.080 |
Why?
|
| CpG Islands | 3 | 2010 | 219 | 0.080 |
Why?
|
| Brain | 2 | 2020 | 1611 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 734 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2010 | 46 | 0.080 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 22 | 0.080 |
Why?
|
| Sex Factors | 2 | 2024 | 995 | 0.080 |
Why?
|
| Paramyxoviridae Infections | 1 | 2009 | 8 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 8 | 0.080 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2009 | 10 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 45 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 160 | 0.080 |
Why?
|
| Bacteria | 1 | 2013 | 336 | 0.080 |
Why?
|
| RNA Polymerase III | 1 | 2009 | 10 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 13 | 0.080 |
Why?
|
| Polyphosphates | 1 | 2009 | 13 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2010 | 79 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2009 | 3 | 0.070 |
Why?
|
| United States | 3 | 2020 | 8149 | 0.070 |
Why?
|
| Phylogeny | 1 | 2010 | 389 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 128 | 0.070 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Interleukin-8 | 2 | 2008 | 96 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 340 | 0.070 |
Why?
|
| Arginase | 1 | 2008 | 7 | 0.070 |
Why?
|
| Cathepsins | 1 | 2009 | 34 | 0.070 |
Why?
|
| Asthma | 1 | 2013 | 485 | 0.070 |
Why?
|
| Unfolded Protein Response | 1 | 2009 | 62 | 0.070 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 3 | 2014 | 16 | 0.070 |
Why?
|
| Isoenzymes | 2 | 2006 | 130 | 0.070 |
Why?
|
| Mice, 129 Strain | 3 | 2014 | 41 | 0.070 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2008 | 11 | 0.070 |
Why?
|
| DNA Primers | 4 | 2014 | 301 | 0.070 |
Why?
|
| Chagas Disease | 1 | 2008 | 37 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2014 | 147 | 0.070 |
Why?
|
| Mice, Inbred C3H | 4 | 2010 | 173 | 0.070 |
Why?
|
| Trypanosoma cruzi | 1 | 2008 | 53 | 0.070 |
Why?
|
| Silicosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 102 | 0.070 |
Why?
|
| RAW 264.7 Cells | 2 | 2018 | 50 | 0.070 |
Why?
|
| Lysine | 1 | 2008 | 93 | 0.070 |
Why?
|
| NADPH Oxidase 2 | 3 | 2013 | 36 | 0.070 |
Why?
|
| HIV-1 | 1 | 2013 | 706 | 0.070 |
Why?
|
| Base Sequence | 4 | 2014 | 1331 | 0.070 |
Why?
|
| Cathepsin L | 2 | 2022 | 21 | 0.070 |
Why?
|
| Adult | 7 | 2024 | 17467 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2025 | 239 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 254 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 93 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 116 | 0.060 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2007 | 16 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 98 | 0.060 |
Why?
|
| Rhabdoviridae Infections | 1 | 2007 | 6 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 2008 | 107 | 0.060 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2007 | 21 | 0.060 |
Why?
|
| Glycolipids | 1 | 2007 | 44 | 0.060 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 26 | 0.060 |
Why?
|
| Onchocerca volvulus | 1 | 2007 | 3 | 0.060 |
Why?
|
| Models, Molecular | 4 | 2014 | 1155 | 0.060 |
Why?
|
| Brugia malayi | 1 | 2007 | 23 | 0.060 |
Why?
|
| Ovalbumin | 2 | 2018 | 108 | 0.060 |
Why?
|
| Wolbachia | 1 | 2007 | 5 | 0.060 |
Why?
|
| Tripartite Motif Proteins | 2 | 2019 | 42 | 0.060 |
Why?
|
| Genomics | 1 | 2010 | 386 | 0.060 |
Why?
|
| Necrosis | 2 | 2017 | 148 | 0.060 |
Why?
|
| Proteome | 2 | 2023 | 152 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2022 | 277 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2015 | 611 | 0.060 |
Why?
|
| Models, Biological | 5 | 2010 | 1192 | 0.060 |
Why?
|
| Chemokine CCL2 | 3 | 2014 | 61 | 0.060 |
Why?
|
| Phosphates | 1 | 2007 | 104 | 0.060 |
Why?
|
| Adoptive Transfer | 2 | 2018 | 145 | 0.060 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2006 | 5 | 0.060 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2006 | 13 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2016 | 176 | 0.060 |
Why?
|
| Disaccharides | 1 | 2026 | 11 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 321 | 0.060 |
Why?
|
| Receptors, IgE | 1 | 2026 | 6 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 251 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 733 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 281 | 0.060 |
Why?
|
| Phospholipids | 1 | 2006 | 81 | 0.060 |
Why?
|
| Parasitemia | 1 | 2025 | 50 | 0.060 |
Why?
|
| Epitopes | 3 | 2022 | 291 | 0.060 |
Why?
|
| Stilbenes | 1 | 2005 | 22 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1276 | 0.060 |
Why?
|
| Serine | 2 | 2020 | 90 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 513 | 0.060 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 65 | 0.060 |
Why?
|
| Dengue | 1 | 2005 | 97 | 0.060 |
Why?
|
| GATA6 Transcription Factor | 1 | 2024 | 3 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2026 | 354 | 0.050 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2024 | 10 | 0.050 |
Why?
|
| Dengue Virus | 1 | 2005 | 100 | 0.050 |
Why?
|
| Disease Resistance | 1 | 2025 | 27 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2025 | 22 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2014 | 281 | 0.050 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2004 | 5 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 23 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 325 | 0.050 |
Why?
|
| Drosophila | 2 | 2013 | 479 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 64 | 0.050 |
Why?
|
| Poxviridae | 1 | 2004 | 5 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2024 | 55 | 0.050 |
Why?
|
| Middle Aged | 5 | 2024 | 18393 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2007 | 790 | 0.050 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2015 | 11 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 95 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2004 | 28 | 0.050 |
Why?
|
| Fibrosis | 2 | 2017 | 172 | 0.050 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 100 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 60 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2024 | 121 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 119 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 344 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 126 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2023 | 23 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 216 | 0.050 |
Why?
|
| Chemokine CXCL10 | 2 | 2014 | 56 | 0.050 |
Why?
|
| Immunity, Mucosal | 2 | 2014 | 53 | 0.050 |
Why?
|
| Adolescent | 4 | 2021 | 6333 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 16 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2024 | 200 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 58 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 512 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2014 | 91 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 25 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2025 | 742 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2023 | 103 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 79 | 0.050 |
Why?
|
| Radiation Chimera | 2 | 2016 | 61 | 0.040 |
Why?
|
| Motor Activity | 1 | 2024 | 346 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 106 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2022 | 57 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2001 | 152 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 55 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 114 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 165 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 38 | 0.040 |
Why?
|
| Mesoderm | 1 | 2001 | 89 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 213 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 293 | 0.040 |
Why?
|
| Animal Experimentation | 1 | 2020 | 4 | 0.040 |
Why?
|
| Microtubule-Organizing Center | 1 | 2020 | 6 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 20 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2012 | 115 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2011 | 29 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2014 | 433 | 0.040 |
Why?
|
| Pyrin Domain | 1 | 2020 | 3 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 294 | 0.040 |
Why?
|
| Plant Diseases | 1 | 2000 | 11 | 0.040 |
Why?
|
| Gene Editing | 1 | 2025 | 331 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2018 | 2067 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2020 | 32 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2020 | 29 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1285 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2001 | 282 | 0.040 |
Why?
|
| Glycolysis | 1 | 2020 | 59 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 92 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2020 | 30 | 0.040 |
Why?
|
| Gout | 1 | 2020 | 48 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 65 | 0.040 |
Why?
|
| Precipitin Tests | 3 | 2004 | 77 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2000 | 93 | 0.040 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| Forecasting | 1 | 2000 | 230 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 148 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 897 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4839 | 0.040 |
Why?
|
| Microtubules | 1 | 2020 | 210 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 501 | 0.040 |
Why?
|
| Transcription Factor RelB | 1 | 2018 | 6 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 297 | 0.040 |
Why?
|
| Lipoylation | 1 | 2018 | 5 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 12 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 579 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2009 | 61 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2020 | 274 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 97 | 0.030 |
Why?
|
| Chromosomes | 1 | 2019 | 139 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 857 | 0.030 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 23 | 0.030 |
Why?
|
| Saliva | 1 | 2018 | 100 | 0.030 |
Why?
|
| Proteolysis | 1 | 2018 | 154 | 0.030 |
Why?
|
| Yersinia | 1 | 2017 | 3 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2017 | 86 | 0.030 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 35 | 0.030 |
Why?
|
| Klebsiella | 1 | 2017 | 11 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 395 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 707 | 0.030 |
Why?
|
| Ubiquitin | 2 | 2009 | 104 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 11 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2016 | 17 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2016 | 33 | 0.030 |
Why?
|
| Genome | 1 | 2019 | 285 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 24 | 0.030 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2016 | 4 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 15062 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 127 | 0.030 |
Why?
|
| Binding Sites | 2 | 2009 | 917 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2016 | 56 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2007 | 128 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 6 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 123 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2015 | 22 | 0.030 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 8 | 0.030 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2015 | 17 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 85 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2007 | 13 | 0.030 |
Why?
|
| Brucella abortus | 1 | 2015 | 6 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 135 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 178 | 0.030 |
Why?
|
| Dynamins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2015 | 18 | 0.030 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2015 | 7 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 52 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2015 | 57 | 0.030 |
Why?
|
| Iron | 1 | 2016 | 155 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 80 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 20 | 0.030 |
Why?
|
| Gonorrhea | 1 | 2017 | 162 | 0.030 |
Why?
|
| RNA, Protozoan | 1 | 2014 | 10 | 0.030 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Drosophila melanogaster | 2 | 2012 | 560 | 0.030 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2014 | 4 | 0.030 |
Why?
|
| Intestine, Large | 1 | 2014 | 7 | 0.030 |
Why?
|
| Vaccines | 1 | 2016 | 97 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 133 | 0.030 |
Why?
|
| Malaria Vaccines | 1 | 2014 | 42 | 0.030 |
Why?
|
| Aerosols | 1 | 2014 | 46 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 408 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 100 | 0.030 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 2014 | 3 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2014 | 5 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2014 | 5 | 0.030 |
Why?
|
| Infant | 2 | 2018 | 1704 | 0.030 |
Why?
|
| Allyl Compounds | 1 | 2013 | 4 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Polymerization | 1 | 2014 | 36 | 0.030 |
Why?
|
| Virulence | 1 | 2014 | 199 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 84 | 0.030 |
Why?
|
| Quinazolines | 1 | 2013 | 21 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 160 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 152 | 0.030 |
Why?
|
| Autoantigens | 1 | 2014 | 140 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 81 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 71 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 51 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 90 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 674 | 0.020 |
Why?
|
| Terpenes | 1 | 2013 | 28 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 213 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 106 | 0.020 |
Why?
|
| Plasmids | 2 | 2004 | 294 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 48 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 5 | 1984 | 875 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 161 | 0.020 |
Why?
|
| Colon | 1 | 2014 | 147 | 0.020 |
Why?
|
| Turpentine | 1 | 2013 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 34 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2014 | 86 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 491 | 0.020 |
Why?
|
| Protein Modification, Translational | 1 | 2012 | 6 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2013 | 25 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 88 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2012 | 1 | 0.020 |
Why?
|
| Oxidants | 1 | 2012 | 18 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2014 | 89 | 0.020 |
Why?
|
| Infection Control | 1 | 2013 | 106 | 0.020 |
Why?
|
| Prion Proteins | 1 | 2012 | 7 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 184 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 180 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 180 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 606 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1565 | 0.020 |
Why?
|
| Kidney | 2 | 2005 | 455 | 0.020 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 498 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 372 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2010 | 194 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 121 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 213 | 0.020 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2012 | 4 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 248 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 181 | 0.020 |
Why?
|
| Cryoelectron Microscopy | 1 | 2014 | 215 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 178 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 106 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 401 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 104 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 27 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 14 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 465 | 0.020 |
Why?
|
| Virus Internalization | 1 | 2012 | 91 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 17 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 233 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 277 | 0.020 |
Why?
|
| Carrier State | 1 | 2011 | 20 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 381 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2011 | 51 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5650 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 350 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 284 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 44 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 328 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 541 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 110 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 536 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 367 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2010 | 57 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 93 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 7 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 30 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 268 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2010 | 14 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2010 | 35 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 186 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 40 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 44 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2010 | 39 | 0.020 |
Why?
|
| Calcium | 1 | 2013 | 584 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 207 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 97 | 0.020 |
Why?
|
| Phagocytes | 1 | 2010 | 52 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 140 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2010 | 90 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 14 | 0.020 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 15 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 70 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2014 | 714 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Pneumonia, Bacterial | 1 | 2010 | 91 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2009 | 8 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 5 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2009 | 7 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 25 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 46 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 102 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 20 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2008 | 9 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2009 | 13 | 0.020 |
Why?
|
| Listeria | 1 | 2008 | 12 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2008 | 22 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2008 | 14 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2008 | 46 | 0.020 |
Why?
|
| Aluminum Compounds | 1 | 2008 | 11 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 238 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 115 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 190 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2009 | 81 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 108 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 196 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 110 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 2008 | 63 | 0.020 |
Why?
|
| Newcastle disease virus | 1 | 2008 | 61 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 173 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2007 | 20 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 210 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2007 | 16 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 300 | 0.020 |
Why?
|
| Wuchereria | 1 | 2007 | 2 | 0.020 |
Why?
|
| Rickettsiaceae Infections | 1 | 2007 | 4 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2007 | 52 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 71 | 0.020 |
Why?
|
| Symbiosis | 1 | 2007 | 36 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 485 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2007 | 86 | 0.020 |
Why?
|
| Protozoan Infections | 1 | 2006 | 3 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 2006 | 8 | 0.020 |
Why?
|
| Diaminopimelic Acid | 1 | 2006 | 8 | 0.020 |
Why?
|
| Condylomata Acuminata | 1 | 2006 | 9 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 1984 | 167 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 8 | 0.020 |
Why?
|
| Brazil | 1 | 2006 | 103 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 2006 | 55 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 11 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 28 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 37 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1983 | 138 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2006 | 80 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2006 | 341 | 0.010 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2005 | 1 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2006 | 315 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 38 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 38 | 0.010 |
Why?
|
| Electroporation | 1 | 2005 | 36 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 2392 | 0.010 |
Why?
|
| Biological Assay | 1 | 2005 | 56 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 806 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 129 | 0.010 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 1984 | 7 | 0.010 |
Why?
|
| Lauric Acids | 1 | 2004 | 2 | 0.010 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2004 | 22 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 45 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 38 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 56 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 129 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 21 | 0.010 |
Why?
|
| Lymphoma | 1 | 1983 | 101 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2633 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2002 | 7 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 42 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 46 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2002 | 46 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 93 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 118 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 141 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 426 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 708 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 410 | 0.010 |
Why?
|
| Clone Cells | 3 | 1984 | 111 | 0.010 |
Why?
|
| Kinetics | 2 | 1984 | 757 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1984 | 13 | 0.000 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 1984 | 25 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1984 | 12 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1984 | 12 | 0.000 |
Why?
|
| Sheep | 1 | 1984 | 194 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1984 | 112 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1983 | 185 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 162 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1984 | 240 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1983 | 96 | 0.000 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1983 | 111 | 0.000 |
Why?
|
| Lymphocytes, Null | 1 | 1982 | 1 | 0.000 |
Why?
|
| Antigens, Heterophile | 1 | 1982 | 1 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1982 | 35 | 0.000 |
Why?
|
| Arthritis, Juvenile | 1 | 1982 | 7 | 0.000 |
Why?
|